| Sign In to gain access to subscriptions and/or personal tools. |
Study of the Population of Enterochromaffin-Like Cells in Mouse Gastric Mucosa after Long-Term Treatment with EbrotidineDepartment of Toxicology, Ferrer Group Research Centre, Cl Juan de Sada 32, 08028-Barcelona, Spain, Department of Cell Biology and Pathological Anatomy, University of Barcelona, Avda. Diagonal s/n, 08028-Barcelona, Spain
Department of Toxicology, Ferrer Group Research Centre, Cl Juan de Sada 32, 08028-Barcelona, Spain
Department of Toxicology, Ferrer Group Research Centre, Cl Juan de Sada 32, 08028-Barcelona, Spain
Department of Toxicology, Ferrer Group Research Centre, Cl Juan de Sada 32, 08028-Barcelona, Spain
Department of Toxicology, Ferrer Group Research Centre, Cl Juan de Sada 32, 08028-Barcelona, Spain The possible hyperplastic effect on the mouse gastric mucosa following administration of 500 mg/kg of ebrotidine for 18 mo was investigated. The animals were taken from the study of carcinogenesis in mouse carried out with this product. Two different aspects were considered to assess such a possible hyperplastic effect. The height of the fundic and antral mucosa was microscopically measured in several points. Histologic sections obtained from standardized levels of the stomach were used. The density of argyrophil cells in the gastric mucosa has been also quantified, in order to identify enterochromaffin-like (ECL) cells, the most abundant among the cells that have this property. Grimelius' silver staining method was used to identify ECL cells. The cell count was performed under x400 magnification, and the length of mucosa examined was determined by computer-assisted image analysis. This study complements the mouse carcinogenesis study, in which no differences in tumor incidence were found between treated and control animals. The results show that administration of 500 mg/kg/day of ebrotidine for 18 mo to mice did not induce any hyperplastic effect on the gastric mucosa comprising its various cell types or any specific, diffuse, or focal hyperplasia of ECL cells.
Key Words: Hyperplasia gastric acid secretion inhibitors
Toxicologic Pathology, Vol. 24, No. 2,
160-165 (1996) |
||||
